Clinical Trial Update: Study Of Airway Physiology In Adults. SERETIDE DISKUS® Inhaler and FLIXOTIDE® Inhaler Are Trademarks of GSK Croup of Companies. [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating airway physiology in adults involving Seretide Diskus and Flixotide inhalers; the asthma trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• FLIXOTIDE Inhaler (fluticasone propionate)
• Seretide Diskus (salmeterol/fluticasone)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma | Phase 4 | Status: COMPLETED